USPTO serial 88629479
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
GEZA C ZIEGLER JR
GEZA C ZIEGLER JR ZIEGLER IP LAW GROUP LLC3135 EASTON TURNPIKESHU I-HUB, W-256Fairfield, CT 06825| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Computer software, namely, downloadable computer software for use in database management relating to the field of science and medicine, in particular, the database relating to medicines, clinical trials, medical and healthcare professionals; Computer software relating to the medical field, namely, downloadable computer software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Downloadable mobile applications for providing information related to the field of science and medicine, the information relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals, scheduling medical appointments and online consultation with medical and healthcare professionals; Software applications for use with mobile devices, namely, downloadable computer software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software for authorising access to data bases; Downloadable computer application software for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for the management of information; Downloadable mobile applications for the transmission of information | ACTIVE | Dec 7, 2021 |
| 042 | Developing computer software; Development and design of software in the field of mobile applications; Medical research services; Medical and pharmacological research services; Research on the subject of pharmaceuticals; Computer programming in the medical field; Scientific investigations for medical purposes; Scientific research for medical purposes in the area of cancerous diseases; Research and development in the pharmaceutical and biotechnology fields; Providing scientific information in the field of medical disorders and their treatment; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Computer software, namely, providing on-line non-downloadable software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Computer software relating to the medical field, namely, providing on-line non-downloadable software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Software applications for use with mobile devices, namely, providing temporary use of a web-based software application for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals | ACTIVE | Dec 7, 2021 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 14, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 14, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 10, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 19, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 7, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 12, 2022 | IUAF | USE AMENDMENT FILED | — |
| Mar 12, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 10, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 10, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 10, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 13, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 13, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 11, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 11, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 11, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 14, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 12, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 12, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 11, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2019 | NWAP | NEW APPLICATION ENTERED | — |